Detalles de la búsqueda
1.
International Society of Urological Pathology (ISUP) Gleason Grade Groups stratify outcomes in the CHHiP Phase 3 prostate radiotherapy trial.
BJU Int
; 133(2): 179-187, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37463104
2.
Observation versus screening spinal MRI and pre-emptive treatment for spinal cord compression in patients with castration-resistant prostate cancer and spinal metastases in the UK (PROMPTS): an open-label, randomised, controlled, phase 3 trial.
Lancet Oncol
; 23(4): 501-513, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35279270
3.
VinCaP: a phase II trial of vinflunine in locally advanced and metastatic squamous carcinoma of the penis.
Br J Cancer
; 126(1): 34-41, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34671131
4.
Linkage of the CHHiP randomised controlled trial with primary care data: a study investigating ways of supplementing cancer trials and improving evidence-based practice.
BMC Med Res Methodol
; 20(1): 198, 2020 07 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-32711460
5.
Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial.
Lancet Oncol
; 20(11): 1531-1543, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31540791
6.
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial.
Lancet Oncol
; 17(8): 1047-1060, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-27339115
7.
Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trial.
Lancet Oncol
; 16(16): 1605-16, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26522334
8.
TORPEdO: A phase III trial of intensity-modulated proton beam therapy versus intensity-modulated radiotherapy for multi-toxicity reduction in oropharyngeal cancer.
Clin Transl Radiat Oncol
; 38: 147-154, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36452431
9.
PEARLS - A multicentre phase II/III trial of extended field radiotherapy for androgen sensitive prostate cancer patients with PSMA-avid pelvic and/or para-aortic lymph nodes at presentation.
Clin Transl Radiat Oncol
; 37: 130-136, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36238579
10.
Local Failure Events in Prostate Cancer Treated with Radiotherapy: A Pooled Analysis of 18 Randomized Trials from the Meta-analysis of Randomized Trials in Cancer of the Prostate Consortium (LEVIATHAN).
Eur Urol
; 82(5): 487-498, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35934601
11.
Impact of Hypofractionated Radiotherapy on Patient-reported Outcomes in Prostate Cancer: Results up to 5 yr in the CHHiP trial (CRUK/06/016).
Eur Urol Oncol
; 4(6): 980-992, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34489210
12.
PIVOTALboost: A phase III randomised controlled trial of prostate and pelvis versus prostate alone radiotherapy with or without prostate boost (CRUK/16/018).
Clin Transl Radiat Oncol
; 25: 22-28, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32995575
13.
Evaluation of erectile potency and radiation dose to the penile bulb using image guided radiotherapy in the CHHiP trial.
Clin Transl Radiat Oncol
; 21: 77-84, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32072028
14.
A randomised assessment of image guided radiotherapy within a phase 3 trial of conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancer.
Radiother Oncol
; 142: 62-71, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31767473
15.
BOXIT-A Randomised Phase III Placebo-controlled Trial Evaluating the Addition of Celecoxib to Standard Treatment of Transitional Cell Carcinoma of the Bladder (CRUK/07/004).
Eur Urol
; 75(4): 593-601, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30279015
16.
Methodology for tissue sample collection within a translational sub-study of the CHHiP trial (CRUK/06/016), a large randomised phase III trial in localised prostate cancer.
Clin Transl Radiat Oncol
; 10: 1-6, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-29928699
17.
The Efficacy and Safety of Conventional and Hypofractionated High-Dose Radiation Therapy for Prostate Cancer in an Elderly Population: A Subgroup Analysis of the CHHiP Trial.
Int J Radiat Oncol Biol Phys
; 100(5): 1179-1189, 2018 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29722660
18.
A phase I study of single administration of antibody-directed enzyme prodrug therapy with the recombinant anti-carcinoembryonic antigen antibody-enzyme fusion protein MFECP1 and a bis-iodo phenol mustard prodrug.
Clin Cancer Res
; 12(21): 6509-16, 2006 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17085666
19.
Linking CHHiP prostate cancer RCT with GP records: A study proposal to investigate the effect of co-morbidities and medications on long-term symptoms and radiotherapy-related toxicity.
Tech Innov Patient Support Radiat Oncol
; 2: 5-12, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32095558
Resultados
1 -
19
de 19
1
Próxima >
>>